506 related articles for article (PubMed ID: 9107241)
1. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding.
Rössle M; Deibert P; Haag K; Ochs A; Olschewski M; Siegerstetter V; Hauenstein KH; Geiger R; Stiepak C; Keller W; Blum HE
Lancet; 1997 Apr; 349(9058):1043-9. PubMed ID: 9107241
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic therapy for the prevention of recurrent esophageal variceal bleeding.
Russo MW; Zacks SL; Sandler RS; Brown RS
Hepatology; 2000 Feb; 31(2):358-63. PubMed ID: 10655258
[TBL] [Abstract][Full Text] [Related]
3. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial.
Lv Y; Qi X; He C; Wang Z; Yin Z; Niu J; Guo W; Bai W; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Liu H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Xia J; Cai H; Yang Z; Wu K; Fan D; Han G;
Gut; 2018 Dec; 67(12):2156-2168. PubMed ID: 28970291
[TBL] [Abstract][Full Text] [Related]
4. Transjugular intrahepatic portosystemic shunt prevents rebleeding in cirrhotic patients having cavernous transformation of the portal vein without improving their survival.
Li LN; Sun XY; Wang GC; Tian XG; Zhang MY; Jiang KT; Zhang CQ
J Dig Dis; 2019 Feb; 20(2):89-96. PubMed ID: 30629804
[TBL] [Abstract][Full Text] [Related]
5. Transjugular intrahepatic portosystemic shunt vs endoscopic therapy in preventing variceal rebleeding.
Xue H; Zhang M; Pang JX; Yan F; Li YC; Lv LS; Yuan J; Palikhe M; Li WZ; Wang ZL
World J Gastroenterol; 2012 Dec; 18(48):7341-7. PubMed ID: 23326143
[TBL] [Abstract][Full Text] [Related]
6. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding.
Sauer P; Theilmann L; Stremmel W; Benz C; Richter GM; Stiehl A
Gastroenterology; 1997 Nov; 113(5):1623-31. PubMed ID: 9352865
[TBL] [Abstract][Full Text] [Related]
7. Small-Diameter Transjugular Intrahepatic Portosystemic Shunt versus Endoscopic Variceal Ligation Plus Propranolol for Variceal Rebleeding in Advanced Cirrhosis.
Wang X; Liu G; Wu J; Xiao X; Yan Y; Guo Y; Yang J; Li X; He Y; Yang L; Luo X
Radiology; 2023 Aug; 308(2):e223201. PubMed ID: 37606572
[TBL] [Abstract][Full Text] [Related]
8. Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis.
Simonetti RG; Perricone G; Robbins HL; Battula NR; Weickert MO; Sutton R; Khan S
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD000553. PubMed ID: 33089892
[TBL] [Abstract][Full Text] [Related]
9. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage.
García-Villarreal L; Martínez-Lagares F; Sierra A; Guevara C; Marrero JM; Jiménez E; Monescillo A; Hernández-Cabrero T; Alonso JM; Fuentes R
Hepatology; 1999 Jan; 29(1):27-32. PubMed ID: 9862845
[TBL] [Abstract][Full Text] [Related]
10. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
[TBL] [Abstract][Full Text] [Related]
11. Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + β-blocker for prevention of variceal rebleeding.
Holster IL; Tjwa ET; Moelker A; Wils A; Hansen BE; Vermeijden JR; Scholten P; van Hoek B; Nicolai JJ; Kuipers EJ; Pattynama PM; van Buuren HR
Hepatology; 2016 Feb; 63(2):581-9. PubMed ID: 26517576
[TBL] [Abstract][Full Text] [Related]
12. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.).
Merli M; Salerno F; Riggio O; de Franchis R; Fiaccadori F; Meddi P; Primignani M; Pedretti G; Maggi A; Capocaccia L; Lovaria A; Ugolotti U; Salvatori F; Bezzi M; Rossi P
Hepatology; 1998 Jan; 27(1):48-53. PubMed ID: 9425916
[TBL] [Abstract][Full Text] [Related]
13. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial.
Pomier-Layrargues G; Villeneuve JP; Deschênes M; Bui B; Perreault P; Fenyves D; Willems B; Marleau D; Bilodeau M; Lafortune M; Dufresne MP
Gut; 2001 Mar; 48(3):390-6. PubMed ID: 11171831
[TBL] [Abstract][Full Text] [Related]
14. Advanced Cirrhosis Combined with Portal Vein Thrombosis: A Randomized Trial of TIPS versus Endoscopic Band Ligation Plus Propranolol for the Prevention of Recurrent Esophageal Variceal Bleeding.
Luo X; Wang Z; Tsauo J; Zhou B; Zhang H; Li X
Radiology; 2015 Jul; 276(1):286-93. PubMed ID: 25759969
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial.
Cello JP; Ring EJ; Olcott EW; Koch J; Gordon R; Sandhu J; Morgan DR; Ostroff JW; Rockey DC; Bacchetti P; LaBerge J; Lake JR; Somberg K; Doherty C; Davila M; McQuaid K; Wall SD
Ann Intern Med; 1997 Jun; 126(11):858-65. PubMed ID: 9163286
[TBL] [Abstract][Full Text] [Related]
16. Combined Transjugular Intrahepatic Portosystemic Shunt Plus Variceal Obliteration versus Transjugular Intrahepatic Portosystemic Shunt Alone for the Management of Gastric Varices: Comparative Single-Center Clinical Outcomes.
Shah KY; Ren A; Simpson RO; Kloster ML; Mikolajczyk A; Bui JT; Lipnik AJ; Niemeyer MM; Ray CE; Gaba RC
J Vasc Interv Radiol; 2021 Feb; 32(2):282-291.e1. PubMed ID: 33485506
[TBL] [Abstract][Full Text] [Related]
17. Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus β-blocker.
Chen Y; Ma X; Zhang X; Luo J; An L; Zhang Y; Chang X; Dong Z; Zhang W; Kong H; Zhao J; Ding H; Liu F; Yang Y
Hepatol Int; 2022 Dec; 16(6):1379-1389. PubMed ID: 36255564
[TBL] [Abstract][Full Text] [Related]
18. Second prophylaxis of variceal bleeding in cirrhotic patients with a high HVPG.
Zhang M; Wang G; Zhao L; Wu Z; Zhang W; Zhang C
Scand J Gastroenterol; 2016 Dec; 51(12):1502-1506. PubMed ID: 27379704
[TBL] [Abstract][Full Text] [Related]
19. Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial.
Sanyal AJ; Freedman AM; Luketic VA; Purdum PP; Shiffman ML; Cole PE; Tisnado J; Simmons S
Ann Intern Med; 1997 Jun; 126(11):849-57. PubMed ID: 9163285
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial.
Sauer P; Hansmann J; Richter GM; Stremmel W; Stiehl A
Endoscopy; 2002 Sep; 34(9):690-7. PubMed ID: 12195325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
